|
|
||||||||
The Annals of Thoracic Surgery, Vol 39, 125-133, Copyright © 1985 by The Society of Thoracic Surgeons
JE Codd, HB Barner, DG Pennington, JP Merjavy, GC Kaiser, JE Devine and VL Willman
Cardiac arrest was achieved in 84 patients using asanguineous cardioplegia
and in 97 patients using cold blood potassium cardioplegia. The patient
groups were similar in age, sex ratio, and preoperative risk factors. Other
than the cardioplegic solution used, the conduct of each operation was
identical. There were no differences in mean total pump time (118 minutes
for the asanguineous cardioplegia group versus 117 minutes for the cold
blood cardioplegia group) or cross-clamp time (73.5 versus 70 minutes,
respectively). However, the blood cardioplegia group had a greater number
of distal anastomoses per patient (3.9 versus 3.7; p less than 0.05).
Myocardial protection was assessed clinically and by serial
electrocardiograms. Cellular integrity was determined by release of the
myocardial isoenzyme of serum creatine kinase (CK-MB). Cellular morphology
was studied in 6 randomly selected patients in each group by electron
microscopic examination of left ventricular myocardial samples obtained
before and after bypass. Three patients given blood cardioplegia and 5
given asanguineous cardioplegia required intraaortic balloon
counterpulsation at termination of bypass. There were no ultrastructural
changes in either group. Electrocardiographic changes (Minnesota code)
occurred in 12 of 84 patients receiving asanguineous cardioplegia versus 12
of 97 patients receiving cold blood potassium cardioplegia. To maintain a
satisfactory cardiac index (greater than 2.0 L/min/m2), 38 of 84 patients
given asanguineous cardioplegia versus 25 of 97 patients given blood
cardioplegia required inotropic support up to 24 hours postoperatively (p
less than 0.05). Infarct size determined from CK-MB release was
significantly greater (p less than 0.05) in patients given asanguineous
cardioplegia (36.27 gm-equivalents) than in those given blood cardioplegia
(26.7 gm-equivalents).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Intraoperative myocardial protection: a comparison of blood and asanguineous cardioplegia
This article has been cited by other articles:
![]() |
A. A Albert, B. Arnrich, J. A Walter, W. M Hassanein, U. P Rosendahl, P. Gehle, F. Schon, and J. Ennker Hyperkalemic Blood versus Crystalloid Cardioplegia in Longer Clamping Times Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 115 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Ibrahim, G. E. Venn, C. P. Young, and D. J. Chambers A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution Eur. J. Cardiothorac. Surg., January 1, 1999; 15(1): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Shanewise, A. S. Kosinski, J. A. Coto, and E. L. Jones Prospective, randomized trial comparing blood and oxygenated crystalloid cardioplegia in reoperative coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1166 - 1171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |